Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Diseases

Free Subscription 20.05.2019 4 AJR Am J Roentgenol 1 Am J Gastroenterol 4 Anticancer Res 3 Biochem Biophys Res Commun 1 BMC Cancer 1 BMC Gastroenterol 1 Dig Dis Sci 2 Eur Radiol 4 Gastroenterology 3 Gut 5 Hepatology 2 Int J Cancer 2 J Comput Assist Tomogr 1 J Gastroenterol Hepatol 1 J Hepatol 1 Lancet HIV 1 Nat Rev Cancer 1 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. JHA RC, Khera SS, Kalaria AD
   Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.
   AJR Am J Roentgenol. 2018 May 24:1-11. doi: 10.2214/AJR.18.19548.
   PubMed     Text format     Abstract available
   
   
2. FURLAN A, Brancatelli G, Vilgrain V
   Reply to "Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI".
   AJR Am J Roentgenol. 2018;211:W134.
   PubMed     Text format    
   
   
3. UNAL E, Karcaaltincaba M
   Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI.
   AJR Am J Roentgenol. 2018;211:W133.
   PubMed     Text format    
   
   
4. PATNANA M, Menias CO, Pickhardt PJ, Elshikh M, et al
   Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT.
   AJR Am J Roentgenol. 2018 Apr 18:1-11. doi: 10.2214/AJR.18.19704.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

5. ROSENBLATT R, Cohen-Mekelburg S
   Fragmentation in Cirrhosis: The Excluded May Reveal the Full Story.
   Am J Gastroenterol. 2019 May 7. doi: 10.14309/ajg.0000000000000250.
   PubMed     Text format    
   
   

   
   Anticancer Res

6. UNO S, Sakai M, Fujinari Y, Hosono T, et al
   Diallyl Trisulfide Enhances Benzo[a]pyrene-induced CYP1A1 Expression and Metabolic Activation in Hepatic HepG2 Cells.
   Anticancer Res. 2019;39:2369-2375.
   PubMed     Text format     Abstract available
   
   
7. NAKAO Y, Yamashita YI, Arima K, Miyata T, et al
   Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study.
   Anticancer Res. 2019;39:2641-2646.
   PubMed     Text format     Abstract available
   
   
8. OMARI J, Heinze C, Damm R, Hass P, et al
   Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy.
   Anticancer Res. 2019;39:2501-2508.
   PubMed     Text format     Abstract available
   
   
9. WENDLING-KEIM D, Vokuhl C, Walz C, Rieder L, et al
   Activation of Hedgehog Signaling in Aggressive Hepatic Hemangioma in Newborns and Infants.
   Anticancer Res. 2019;39:2351-2360.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

10. HU XX, Feng J, Huang XW, Lu PZ, et al
    Histone deacetylases up-regulate C/EBPalpha expression through reduction of miR-124-3p and miR-25 in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2019 May 12. pii: S0006-291X(19)30892.
    PubMed     Text format     Abstract available
    
    
11. LI Y, Zhuang W, Huang M, Li X, et al
    Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2019 May 13. pii: S0006-291X(19)30911.
    PubMed     Text format     Abstract available
    
    
12. WANG YH, Huang S, Zhu L, Yang Q, et al
    Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2019 May 7. pii: S0006-291X(19)30852.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

13. POPP B, Agaimy A, Kraus C, Knaup KX, et al
    Dissecting TSC2-mutated renal and hepatic angiomyolipomas in an individual with ARID1B-associated intellectual disability.
    BMC Cancer. 2019;19:435.
    PubMed     Text format     Abstract available
    
    

    
    BMC Gastroenterol

14. LI L, Mo F, Hui EP, Chan SL, et al
    The association of liver function and quality of life of patients with liver cancer.
    BMC Gastroenterol. 2019;19:66.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

15. CORBI LE, Tannuri ACA, de Aro Braz MJ, Paes VR, et al
    Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Dig Dis Sci. 2019 May 10. pii: 10.1007/s10620-019-05658.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

16. KIM YC, Min JH, Kim YK, Lee SJ, et al
    Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS.
    Eur Radiol. 2019;29:2058-2068.
    PubMed     Text format     Abstract available
    
    
17. GROSSE HOKAMP N, Abdullayev N, Persigehl T, Schlaak M, et al
    Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data.
    Eur Radiol. 2019;29:2098-2106.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

18. CIRULLI ET, Nicoletti P, Abramson K, Andrade RJ, et al
    A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Gastroenterology. 2019;156:1707-1716.
    PubMed     Text format     Abstract available
    
    
19. WIDJAJA AA, Singh BK, Adami E, Viswanathan S, et al
    Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2019 May 8. pii: S0016-5085(19)40858.
    PubMed     Text format     Abstract available
    
    
20. EDDOWES PJ, Sasso M, Allison M, Tsochatzis E, et al
    Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1717-1730.
    PubMed     Text format     Abstract available
    
    
21. LI H, Li CW, Li X, Ding Q, et al
    MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.
    Gastroenterology. 2019;156:1849-1861.
    PubMed     Text format     Abstract available
    
    

    
    Gut

22. KRENKEL O, Hundertmark J, Abdallah AT, Kohlhepp M, et al
    Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.
    Gut. 2019 May 10. pii: gutjnl-2019-318382. doi: 10.1136/gutjnl-2019-318382.
    PubMed     Text format     Abstract available
    
    
23. LIU M, Zhou J, Liu X, Feng Y, et al
    Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Gut. 2019 May 10. pii: gutjnl-2018-317257. doi: 10.1136/gutjnl-2018-317257.
    PubMed     Text format     Abstract available
    
    
24. RUIZ DE GALARRETA M, Lujambio A
    Hepatocellular carcinoma: killing one bird with two stones.
    Gut. 2019 May 10. pii: gutjnl-2019-318649. doi: 10.1136/gutjnl-2019-318649.
    PubMed     Text format    
    
    

    
    Hepatology

25. YAN ZZ, Huang YP, Wang X, Wang HP, et al
    Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia-Reperfusion Injury in Mice.
    Hepatology. 2019 May 11. doi: 10.1002/hep.30705.
    PubMed     Text format     Abstract available
    
    
26. CHOUDHARY NS, Saigal S, Saraf N, Soin AS, et al
    Prognostic role of ammonia in cirrhotic patients.
    Hepatology. 2019 May 11. doi: 10.1002/hep.30758.
    PubMed     Text format     Abstract available
    
    
27. GLUCHOWSKI NL, Gabriel KR, Chitraju C, Bronson RT, et al
    Hepatocyte Deletion of Triglyceride-Synthesis Enzyme DGAT2 Reduces Steatosis without Increasing Inflammation or Fibrosis.
    Hepatology. 2019 May 13. doi: 10.1002/hep.30765.
    PubMed     Text format     Abstract available
    
    
28. JIANG N, Li X, Xing YF, Qiao YD, et al
    Local regional therapy before liver transplantation for hepatocellular carcinoma.
    Hepatology. 2019 May 15. doi: 10.1002/hep.30769.
    PubMed     Text format     Abstract available
    
    
29. PERRET C, Decaens T
    mTOR inhibitors, new drugs for CTNNB1-mutated hepatocellular carcinomas?
    Hepatology. 2019 May 16. doi: 10.1002/hep.30768.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

30. YANG Y, Chen Q, Piao HY, Wang B, et al
    HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
    Int J Cancer. 2019 May 15. doi: 10.1002/ijc.32409.
    PubMed     Text format     Abstract available
    
    
31. YIN S, Qiu Y, Jin C, Wang R, et al
    7-deoxynarciclasine shows promising antitumor efficacy by targeting Akt against hepatocellular carcinoma.
    Int J Cancer. 2019 May 13. doi: 10.1002/ijc.32395.
    PubMed     Text format     Abstract available
    
    

    
    J Comput Assist Tomogr

32. FUENTES D, Ahmed K, Lin JS, Abdel-Wahab R, et al
    Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study.
    J Comput Assist Tomogr. 2019;43:499-506.
    PubMed     Text format     Abstract available
    
    
33. FUENTES D, Ahmed K, Lin JS, Abdel-Wahab R, et al
    Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study.
    J Comput Assist Tomogr. 2019 May 6. doi: 10.1097/RCT.0000000000000866.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

34. DEZSO K, Nagy P, Paku S
    Human liver regeneration following massive hepatic necrosis - two distinct patterns.
    J Gastroenterol Hepatol. 2019 May 14. doi: 10.1111/jgh.14721.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

35. JI F, Yeo YH, Wei MT, Ogawa E, et al
    Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
    J Hepatol. 2019 May 13. pii: S0168-8278(19)30279.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

36. ALTHOFF KN, Gebo KA, Moore RD, Boyd CM, et al
    Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
    Lancet HIV. 2019 Jan 22. pii: S2352-3018(18)30295.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Cancer

37. HARJES U
    Dividing paths in fatty liver disease.
    Nat Rev Cancer. 2019;19:5.
    PubMed     Text format    
    
    

    
    PLoS One

38. SCHUBERT M, Hackl H, Gassner FJ, Greil R, et al
    Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0208753.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

39. JENG KS, Huang CC, Lin CK, Lin CC, et al
    Reappraisal of Failures in Downstaging Treatment of Hepatocellular Carcinoma Prior to Liver Transplant-Preliminary Report on the Impact of Underestimations of Tumor Numbers and Tumor Sizes as Measured From Imaging Before Transplant.
    Transplant Proc. 2019 May 9. pii: S0041-1345(19)30214.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: